West Pharmaceutical Services Inc (NYSE:WST)
$ 353.065 -1.045 (-0.3%) Market Cap: 25.72 Bil Enterprise Value: 25.50 Bil PE Ratio: 46.58 PB Ratio: 9.62 GF Score: 95/100

West Pharmaceutical Services Inc at UBS Global Healthcare Conference Transcript

May 21, 2019 / 01:00PM GMT
Release Date Price: $118.53 (+0.93%)
Daniel Gregory Brennan;Quintin J. Lai
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Welcome, everyone, to day 2 of the UBS Global Healthcare Conference. My name is Dan Brennan. I cover tools diagnostics and pharma services. Pleased to be joined on stage with senior management from West Pharma to my left. I have Bernard Birkett, who is the CFO and Treasurer; and to his left is Quintin Lai, who is VP of Corporate Development Strategy and IR.

Before we get started, just -- I want to direct you to the UBS website, www.ubs.com, where you can view all the analyst disclaimer information. So I think we're going to do this. I think management or maybe Quintin -- management is going to provide a brief introduction of the business. And then with that, I'll go into series of questions and I'll stop, periodically to look up and would love some audience participation. So don't be shy.

So with that, gentlemen, thank you for coming. And Quintin, if you want to kick it off.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot